Growth Hormone in EB

Cairo University (CU)

Status: Unknown

Conditions: Epidermolysis Bullosa Dystrophica

Treatments: Diagnostic Test: growth hormone level and insulin like growth factor 1

Study type: Observational

Funder types: Other

Identifiers

NCT05390073

Growth in EB

Details and patient eligibility

About

Growth is extremely affected in epidermolysis bullosa patients

Full description

Studying the role of growth hormone and ILGF-1 in EB may pave the to new therapeutic modality that could improve the growth in those children and avoid the irreversible sequelae that affected subjects experience after adulthood

Enrollment: 50 estimated patients

Sex: All

Ages: 1 month to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children with EB dystrophica

Exclusion criteria

• Adults with the same disease